Ready-to-Use Versus Traditional IV Piggyback Preparation: A Combined Process-Error, Workforce-Time-Waste, and Cost-Effectiveness Analysis

Background: Manual IV medication preparation requires multiple discrete steps, each a potential point of process deviation, while manufacturer-prepared ready-to-use (MP-RTU) products avoid many manual compounding steps. The peer-reviewed literature describing and quantifying real-world process-error and workforce-time-waste (WTW) differences between traditional IV piggyback (IVPB) and MP-RTU products remains limited. Methods: Two complementary studies were conducted. The Alpha study was a prospective, direct-observation study of 100 micafungin (47 steps) and 100 norepinephrine (15 steps) preparations at a 541-bed hospital. The Bravo study was a retrospective operational analysis of utilization, request burden, time to administration, and preparation cost for four medications at a 615-bed hospital. The results informed a decision-analytic cost-effectiveness model (1-year horizon, health-system perspective) comparing MP-RTU with IVPB, with sensitivity analyses. Results: Micafungin preparations contained 208 process errors (4.4%; 67% with ≥1 error), concentrated in drug withdrawal, syringe assembly, and material collection; norepinephrine preparations contained 100 errors (6.7%; 70% with ≥1 error), concentrated in hood preparation/compounding. Pharmacy-prepared insulin and vasopressin showed higher request burden and roughly 2 h longer time to administration than MP-RTU equivalents. MP-RTU dominated IVPB in the model, with a base-case incremental cost-effectiveness ratio of −$4954.15 per additional error avoided, robust across sensitivity analyses. Conclusions: Manual IV preparation introduced process error and operational burden that was either reduced or absent with MP-RTU; this was also less costly and more effective in the model. The findings support considering process-error opportunity and operational burden, not acquisition cost alone, when evaluating IV medication-preparation strategies.

Authors

Publication Details

Journal
Pharmacy
Published
2026-11-11
DOI
https://doi.org/10.3390/pharmacy14080169
Primary Topic
Patient Safety and Medication Errors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ready-to-Use Versus Traditional IV Piggyback Preparation: A Combined Process-Error, Workforce-Time-Waste, and Cost-Effectiveness Analysis

John B. Hertig, Prachi Arora, Les Louden, Michael Stepanovic et al.
1 links
Pharmacy
Patient Safety and Medication Errors
article

Ready-to-Use Versus Traditional IV Piggyback Preparation: A Combined Process-Error, Workforce-Time-Waste, and Cost-Effectiveness Analysis

John B. Hertig, Prachi Arora, Les Louden, Michael Stepanovic, Daniel Degnan, William P. Raley
article en

Abstract

Background: Manual IV medication preparation requires multiple discrete steps, each a potential point of process deviation, while manufacturer-prepared ready-to-use (MP-RTU) products avoid many manual compounding steps. The peer-reviewed literature describing and quantifying real-world process-error and workforce-time-waste (WTW) differences between traditional IV piggyback (IVPB) and MP-RTU products remains limited. Methods: Two complementary studies were conducted. The Alpha study was a prospective, direct-observation study of 100 micafungin (47 steps) and 100 norepinephrine (15 steps) preparations at a 541-bed hospital. The Bravo study was a retrospective operational analysis of utilization, request burden, time to administration, and preparation cost for four medications at a 615-bed hospital. The results informed a decision-analytic cost-effectiveness model (1-year horizon, health-system perspective) comparing MP-RTU with IVPB, with sensitivity analyses. Results: Micafungin preparations contained 208 process errors (4.4%; 67% with ≥1 error), concentrated in drug withdrawal, syringe assembly, and material collection; norepinephrine preparations contained 100 errors (6.7%; 70% with ≥1 error), concentrated in hood preparation/compounding. Pharmacy-prepared insulin and vasopressin showed higher request burden and roughly 2 h longer time to administration than MP-RTU equivalents. MP-RTU dominated IVPB in the model, with a base-case incremental cost-effectiveness ratio of −$4954.15 per additional error avoided, robust across sensitivity analyses. Conclusions: Manual IV preparation introduced process error and operational burden that was either reduced or absent with MP-RTU; this was also less costly and more effective in the model. The findings support considering process-error opportunity and operational burden, not acquisition cost alone, when evaluating IV medication-preparation strategies.

PharmacyVol. 14(8)
Good health and well-being
Patient Safety and Medication Errors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon